Showing results (141-150 of 156) with videos related to
Sort By:
Pageof 16
Bioengineering (Basel, Switzerland)|May 27, 2022
Cardiac Function after Modern Radiation Therapy with Volumetric Modulated Arc Therapy or Helical Tomotherapy for Advanced Left-Breast Cancer Receiving Regional Nodal IrradiationPei-Yu Hou, Chen-Hsi Hsieh, Le-Jung Wu, et al.Case Reports in Otolaryngology|October 7, 2022
Spotted Temporal Lobe Necrosis following Concurrent Chemoradiation Therapy Using Image-Guided Radiotherapy for Nasopharyngeal CarcinomaYu-Wei Chiang, Li-Jen Liao, Chia-Yun Wu, et al.Stem Cells and Development|September 3, 2005
Genetic engineering of human embryonic stem cells with lentiviral vectorsChen Xiong, Dong-Qi Tang, Chang-Qing Xie, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 18, 2023
Postchemoradiotherapy systemic inflammation response index predicts treatment response and overall survival for patients with locally advanced nasopharyngeal cancerYueh-Feng Lu, Chia-Yun Wu, Wu-Chia Lo, et al.Frontiers in Pharmacology|July 3, 2019
A Novel Antiplatelet Aggregation Target of Justicidin B Obtained From Rostellularia Procumbens (L.) NeesYan-Fang Yang, Song-Tao Wu, Bo Liu, et al.Cellular & Molecular Immunology|January 24, 2024
Disulfiram ameliorates STING/MITA-dependent inflammation and autoimmunity by targeting RNF115Zhi-Dong Zhang, Chang-Rui Shi, Fang-Xu Li, et al.Thoracic Cancer|September 27, 2022
Integrating 18 F-FDG PET/CT with lung dose-volume for assessing lung inflammatory changes after arc-based radiotherapy for esophageal cancer: A pilot studyChen-Xiong Hsu, Kuan-Heng Lin, Pei-Wei Shueng, et al.Cell Death & Disease|August 25, 2025
Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinomaYu-Chuan Yan, Li-Juan Shao, Guang-Xiao Meng, et al.Scientific Reports|October 26, 2017
Definitive Radiotherapy for Older Patients with Prostate Cancer: Experience of a Medical Center in TaiwanYuan-Hung Wu, Wan-Chin Yang, Yu-Wen Hu, et al.Molecular Cell|December 5, 2024
p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosisQuan Liao, Jun Deng, Jing Tong, et al.Pageof 16